Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPD
Hiroyuki Ohbayashi,1,2 Mitsuru Adachi21Department of Allergy and Respiratory Medicine, Tohno-Kousei Hospital, Gifu; 2Department of Respiratory and Allergy Medicine, Showa University, Tokyo, JapanBackground: The clinical efficacy of short-acting β2-agonists administered before performing...
Main Authors: | Ohbayashi H, Adachi M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-06-01
|
Series: | International Journal of General Medicine |
Online Access: | http://www.dovepress.com/pretreatment-with-inhaled-procaterol-improves-symptoms-of-dyspnea-and--a10119 |
Similar Items
-
Inhalation and Incubation with Procaterol Increases Diaphragm Muscle Contractility in Mice
by: Chiyohiko Shindoh, et al.
Published: (2007-01-01) -
Aerosol Characteristics of Admixture of Budesonide Inhalation Suspension with a Beta2-Agonist, Procaterol
by: Toshiko Itazawa, et al.
Published: (2013-01-01) -
Effect of inhaled procaterol and budesonide on right ventricular diastolic function in children with asthma
by: Alit Utamayasa, et al.
Published: (2009-07-01) -
Comparing the effectiveness of MDI form of Procaterol with oral form in COPD under mechanically ventilated patients
by: Yao-Chen, et al. -
Health-related quality of life, lung function and dyspnea rating in COPD patients
by: M. Justine, et al.
Published: (2013-12-01)